Drug intelligence / Profile preview

Ba Wei Ai Gu Ning Granules

Development stage
Preclinical
Lead developer
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Ba Wei Ai Gu Ning Granules is a traditional Chinese medicine (TCM) herbal formulation used in China. It is administered as granules and has been studied in the context of treating bone metastasis in lung cancer, as evidenced by a prospective multicenter randomized double-blind controlled study. The precise composition of the formula is not detailed in available English-language sources, but based on TCM naming conventions, "Ba Wei" indicates it contains eight herbal ingredients. The mechanism of action is presumed to be multi-targeted, typical for TCM formulas, potentially involving immunomodulation, anti-inflammatory effects, and support for organ function according to TCM theory. Its primary indication appears to be supportive care or adjunctive therapy for patients with bone metastases from lung cancer[1]. There are no details about its use outside clinical research settings or approval status outside China.

Brand names
Ba Wei Ai Gu Ning Granules
Other names
Bawei Aiguning Granules

Beyond the preview

Go deeper on Ba Wei Ai Gu Ning Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ba Wei Ai Gu Ning Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call